Academic Journal

Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer

التفاصيل البيبلوغرافية
العنوان: Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer
المؤلفون: Han, Rui, Lu, Cong-hua, Hu, Chen, Dou, Yuan-yao, Kang, Jun, Lin, Cai-yu, Wu, Di, Jiang, Wei-ling, Yin, Guo-qing, He, Yong
المصدر: Acta Pharmacologica Sinica ; volume 45, issue 6, page 1264-1275 ; ISSN 1671-4083 1745-7254
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2024
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41401-024-01237-4
الاتاحة: http://dx.doi.org/10.1038/s41401-024-01237-4
https://www.nature.com/articles/s41401-024-01237-4.pdf
https://www.nature.com/articles/s41401-024-01237-4
Rights: https://www.springernature.com/gp/researchers/text-and-data-mining ; https://www.springernature.com/gp/researchers/text-and-data-mining
رقم الانضمام: edsbas.13C166C4
قاعدة البيانات: BASE
الوصف
DOI:10.1038/s41401-024-01237-4